JNDOF yields 3.09% · PFE yields 6.13%● Live data
📍 JNDOF pulled ahead of the other in Year 1
Combined, JNDOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JNDOF + PFE for your $10,000?
JINS HOLDINGS Inc., through its subsidiaries, engages in the planning, manufacturing, sales, and import/export of eyewear and fashion accessories in Japan. It offers airframes; computer glasses under the JINS SCREEN name; JINS Switch, an eyewear that uses magnet to attach sunglasses to frame; children's glasses; JINS VIOLET lenses for selectively block harmful light; JINS MEME, an eyewear, which enables visualization of one's physical and mental state; and contact lenses under the JINS 1DAY name through stores under the JINS Shibuya, JINS Harajuku, and rim of jins LUMINE Shinjuku names, as well through online and other channels. The company is also involved in the operation of shared workspaces; developing and selling work environment products; provision of workspace consulting; and contracting business for agriculture work. In addition, it operates bakery cafes. The company was formerly known as JINS Inc. and changed its name to JINS HOLDINGS Inc. in July 2019. JINS HOLDINGS Inc. was incorporated in 1988 and is headquartered in Tokyo, Japan.
Full JNDOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.